Global experts gather in Brisbane for scientific meeting dedicated to influenza

The arrival of the No Surprises Act led to the unraveling of Envision’s “secret sauce” business model, according to a prominent healthcare economist, and ultimately

In a single-center case series to evaluate the efficacy and safety of high-dose upadacitinib (Rinvoq) for the treatment of inpatients with acute severe ulcerative colitis